Matches in SemOpenAlex for { <https://semopenalex.org/work/W3041710330> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- W3041710330 abstract "Introduction: The renin-angiotensin-aldosterone system (RAAS) has long been established as being a key cascade or pathway in the regulation of blood pressure and homeostasis of body fluid volume. The aspartic protease renin is responsible for the initial and rate-limiting step of the RAAS, thus inhibition of renin would favor more complete blockade of the RAAS. Therefore, direct renin inhibitors (DRIs) have been considered to be attractive agents for the treatment of hypertension. However, from the medicinal chemistry point of view, the identification of orally bioavailable, efficacious and safe low molecular weight DRIs has proven very challenging. To date, Aliskiren (Tekturna®, Rasilez®; Novartis) is the only DRI that has reached the market (FDA approved in 2007) for the treatment of hypertension.Areas covered: The present review summarizes the recent scientific accounts describing the design of new non-peptidic DRIs published from 2009-2012. Chemical structures, and preclinical DMPK properties and safety profile are collected from public scientific literatures and patent filings identified in both the Thomson Pharma and SciFinder databases. The results of early clinical trials of new candidate DRIs are also discussed.Expert opinion: The vast medicinal chemistry efforts on structure-based design of non-peptidic DRIs since the last decade have identified new chemical spaces for tight binding to renin and for gaining proper balance of physicochemical properties, potency, efficacy, and safety. However, the criteria for the selection of development candidates have become increasingly demanding, because new antihypertensives are expected to demonstrate a clear differentiation in their clinical profile, in addition to blood pressure lowering and to the benefit of the patients, as compared to established drug treatment paradigms. Hence, developing a new generation of DRIs remains a formidable task." @default.
- W3041710330 created "2020-07-16" @default.
- W3041710330 creator A5026845080 @default.
- W3041710330 date "2013-04-18" @default.
- W3041710330 modified "2023-09-28" @default.
- W3041710330 title "Recent progress on the discovery of non-peptidic direct renin inhibitors as antihypertensives" @default.
- W3041710330 hasPublicationYear "2013" @default.
- W3041710330 type Work @default.
- W3041710330 sameAs 3041710330 @default.
- W3041710330 citedByCount "0" @default.
- W3041710330 crossrefType "journal-article" @default.
- W3041710330 hasAuthorship W3041710330A5026845080 @default.
- W3041710330 hasConcept C126322002 @default.
- W3041710330 hasConcept C127413603 @default.
- W3041710330 hasConcept C185592680 @default.
- W3041710330 hasConcept C188198153 @default.
- W3041710330 hasConcept C198710026 @default.
- W3041710330 hasConcept C2777425892 @default.
- W3041710330 hasConcept C2779838083 @default.
- W3041710330 hasConcept C55493867 @default.
- W3041710330 hasConcept C60644358 @default.
- W3041710330 hasConcept C71924100 @default.
- W3041710330 hasConcept C74187038 @default.
- W3041710330 hasConcept C78519656 @default.
- W3041710330 hasConcept C84393581 @default.
- W3041710330 hasConcept C86803240 @default.
- W3041710330 hasConcept C98274493 @default.
- W3041710330 hasConceptScore W3041710330C126322002 @default.
- W3041710330 hasConceptScore W3041710330C127413603 @default.
- W3041710330 hasConceptScore W3041710330C185592680 @default.
- W3041710330 hasConceptScore W3041710330C188198153 @default.
- W3041710330 hasConceptScore W3041710330C198710026 @default.
- W3041710330 hasConceptScore W3041710330C2777425892 @default.
- W3041710330 hasConceptScore W3041710330C2779838083 @default.
- W3041710330 hasConceptScore W3041710330C55493867 @default.
- W3041710330 hasConceptScore W3041710330C60644358 @default.
- W3041710330 hasConceptScore W3041710330C71924100 @default.
- W3041710330 hasConceptScore W3041710330C74187038 @default.
- W3041710330 hasConceptScore W3041710330C78519656 @default.
- W3041710330 hasConceptScore W3041710330C84393581 @default.
- W3041710330 hasConceptScore W3041710330C86803240 @default.
- W3041710330 hasConceptScore W3041710330C98274493 @default.
- W3041710330 hasLocation W30417103301 @default.
- W3041710330 hasOpenAccess W3041710330 @default.
- W3041710330 hasPrimaryLocation W30417103301 @default.
- W3041710330 hasRelatedWork W2014165044 @default.
- W3041710330 isParatext "false" @default.
- W3041710330 isRetracted "false" @default.
- W3041710330 magId "3041710330" @default.
- W3041710330 workType "article" @default.